cas 915087-32-0|| where to buy 4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

Nombre del producto:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

Unidad de embalaje	Stock disponible	Precio($)
CM329948-100mg	in stock	ƦƀƦ
CM329948-250mg	in stock	ǊƀƦ
CM329948-1g	in stock	ƀțȬ
CM329948-5g	1-2 Weeks	ƦȁưƦ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 915087-32-0 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :915087-32-0; Fórmula molecular:C12H14FN3O; Punto de fusión:-; Código de sonrisas:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F; Densidad:

: Número de catálogo:CM329948; Peso molecular:235.26; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Enzalutamide; Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.